Los Angeles Capital Management LLC Pacific Biosciences Of California, Inc. Transaction History

Los Angeles Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$8.23 - $13.93 $6,682 - $11,311	812 Added 5.22%	16,359 $136,000
Q2 2023 Aug 03, 2023	BUY	$9.97 - $14.05 $155,003 - $218,435	15,547 New	15,547 $206,000
Q3 2022 Nov 02, 2022	BUY	$3.93 - $8.57 $216 - $471	55 Added 0.2%	27,526 $160,000
Q2 2022 Aug 05, 2022	BUY	$4.02 - $10.43 $21,748 - $56,426	5,410 Added 24.52%	27,471 $121,000
Q4 2021 Feb 03, 2022	SELL	$19.26 - $30.08 $11,825 - $18,469	-614 Reduced 2.71%	22,061 $451,000
Q2 2021 Aug 05, 2021	SELL	$22.3 - $36.02 $101,688 - $164,251	-4,560 Reduced 16.74%	22,675 $793,000
Q1 2021 May 05, 2021	SELL	$26.38 - $51.15 $392,402 - $760,856	-14,875 Reduced 35.32%	27,235 $907,000
Q4 2020 Feb 04, 2021	SELL	$10.5 - $28.5 $1.84 Million - $4.99 Million	-175,170 Reduced 80.62%	42,110 $1.09 Million
Q3 2020 Nov 02, 2020	SELL	$3.61 - $9.87 $85,120 - $232,724	-23,579 Reduced 9.79%	217,280 $2.15 Million
Q2 2020 Aug 05, 2020	BUY	$2.65 - $4.03 $638,276 - $970,661	240,859 New	240,859 $830,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.